Author:
Sivera Raphaël,Delingette Hervé,Lorenzi Marco,Pennec Xavier,Ayache Nicholas
Funder
Université Côte d’Azur
Inria Sophia Antipolis - Méditerranée
Alzheimer's Disease Neuroimaging Initiative
National Institutes of Health
DOD ADNI
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimer's Drug Discovery Foundation
Araclon Biotech
BioClinica, Inc.
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc
Cogstate
Eisai Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd
Genentech, Inc.
Fujirebio
GE Healthcare
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Lumosity; Lundbeck; Merck & Co., Inc.
Meso Scale Diagnostics, LLC.
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Piramal Imaging
Servier
Takeda Pharmaceutical Company
Transition Therapeutics
The Canadian Institutes of Health Research
Subject
Cognitive Neuroscience,Neurology
Reference51 articles.
1. Alzheimer's disease facts and figures;Alzheimer’s Association and others;Alzheimer's Dementia,2017
2. A log-euclidean framework for statistics on diffeomorphisms;Arsigny,2006
3. A multivariate nonlinear mixed effects model for longitudinal image analysis: application to amyloid imaging;Bilgel;Neuroimage,2016
4. Atlas stratification;Blezek;Med. Image Anal.,2007
5. Contributions to 3d diffeomorphic atlas estimation: application to brain images. Medical Image Computing and Computer-Assisted Intervention-MICCAI;Bossa,2007